Envoy Medical Future Growth
Future criteria checks 2/6
Envoy Medical is forecast to grow earnings and revenue by 0.5% and 75.8% per annum respectively while EPS is expected to grow by 5.7% per annum.
Key information
0.5%
Earnings growth rate
5.7%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 75.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 0 | -25 | N/A | -22 | 4 |
| 12/31/2024 | 0 | -26 | N/A | -21 | 4 |
| 9/30/2024 | 0 | -25 | -27 | -25 | N/A |
| 6/30/2024 | 0 | -16 | -22 | -21 | N/A |
| 3/31/2024 | 0 | -24 | -21 | -20 | N/A |
| 12/31/2023 | 0 | -30 | -18 | -18 | N/A |
| 9/30/2023 | 0 | -37 | -8 | -8 | N/A |
| 6/30/2023 | 0 | -38 | -12 | -12 | N/A |
| 3/31/2023 | 0 | -27 | -10 | -10 | N/A |
| 12/31/2022 | 0 | -16 | -9 | -9 | N/A |
| 12/31/2021 | 0 | -9 | -7 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: COCH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: COCH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: COCH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: COCH's revenue (75.8% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: COCH's revenue (75.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COCH's Return on Equity is forecast to be high in 3 years time